Health - Mergers and Acquisitions

As the health sector evolves post-pandemic, M&A activity is expected to increase due to consolidation and cross-border activity. Companies are looking for ways to improve patient care, boost revenues and market share.

Executing deals in a heavily regulated sector such as healthcare can be complicated. Companies require guidance on everything from valuation setting and due diligence processes to negotiations and intellectual property issues. They also often need help understanding a potential target’s supply chain contracts, employee obligations, and pension and benefit requirements.

Osler’s Health Industry team has the deep knowledge needed to help health companies successfully transact in this changing sector. We often advise on the business opportunities and operational challenges in the healthcare M&A space. We have worked with hospitals, long-term care facilities, private equity firms, medical cannabis companies and software start-ups. 

As the healthcare sector continues to innovate, Osler can provide strategic advice to your organization on M&A opportunities.

Recent experience


Animalcare in its agreement with Kane Biotech to form a new subsidiary, STEM Animal Health Inc. The agreement will enable Animalcare and Kane Biotech to collaborate on the development of new biofilm treatments for animals and commercialize Kane Biotech’s oral care products for companion animals in Europe and Asia markets.

Learn more about our work with Animalcare
Veterinarian using a stethoscope on a golden retriever

Abacus Health Products

Abacus Health Products in its acquisition by Charlotte’s Web. The acquisition combines the resources of Charlotte’s Web and Abacus to create the world’s largest vertically integrated hemp-derived CBD company and provides Abacus with the advantages of joining an established platform and a low cost vertical supply chain. 

Learn more about our work with Abacus Health Products
CBD oil pipette

Stryker Corporation

Stryker Corporation in its US$701 million acquisition of NOVADAQ Technologies Inc. Stryker Corporation is one of the world's leading medical technology companies. NOVADAQ'S innovative fluorescence imaging technology expands Stryker’s product offerings into open and plastic reconstructive surgery.

Learn more about our work with Stryker Corporation
Male surgeon looking at a monitor in an operating room

Acasti Pharma Inc.

Acasti in its definitive agreement to acquire Grace Therapeutics, a biopharmaceutical company developing innovative drug delivery technologies for rare and orphan diseases. Acasti will acquire Grace’s pipeline of drug candidates addressing critical unfulfilled medical needs.

Learn more about our work with Acasti Pharma Inc.
lab technician using a pipette to prepare samples of colourful bottled chemicals
Find more deals and cases


Related industry

Related service